Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-22

Clinical Trial Update: Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome [NA]

View source ↗

Summary

This study compared very low frequency magnetic field therapy to the supplement Xinepa for Carpal Tunnel Syndrome; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Very Low Frequency Magnetic Fields
  • Xinepa

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Carpal Tunnel Syndrome | NA | Status: COMPLETED